Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:16 pm Sale | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 5,753,833 4.000% | -4,232,299 (-42.38%) | Filing History |
| 2025-11-14 4:16 pm Purchase | 2025-09-30 | 13G | Cybin Inc. CYBN | Point72 Asset Management, L.P. | 6,410,778 9.900% | 4,804,461 (+299.10%) | Filing History |
| 2025-11-14 4:15 pm Purchase | 2025-09-30 | 13G | Confluent, Inc. CFLT | Point72 Asset Management, L.P. | 17,531,813 6.000% | 3,070,908 (+21.24%) | Filing History |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | Turnstone Biologics Corp. TSBX | Point72 Asset Management, L.P. | 0 0.000% | -1,383,314 (Position Closed) | Filing History |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | PepGen Inc. PEPG | Point72 Asset Management, L.P. | 2,067,432 3.000% | -608,505 (-22.74%) | Filing History |
| 2025-11-14 4:13 pm Sale | 2025-09-30 | 13G | Mobileye Global Inc. MBLY | Point72 Asset Management, L.P. | 6,007,310 2.800% | -238,787 (-3.82%) | Filing History |
| 2025-11-14 4:12 pm Purchase | 2025-09-30 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 1,578,069 6.200% | 50,139 (+3.28%) | Filing History |
| 2025-11-14 4:12 pm Sale | 2025-09-30 | 13G | Replimune Group, Inc. REPL | Point72 Asset Management, L.P. | 3,629,902 4.700% | -832,598 (-18.66%) | Filing History |
| 2025-11-14 4:11 pm Purchase | 2025-09-30 | 13G | FG Nexus Inc. FGNX | Point72 Asset Management, L.P. | 4,000,000 9.900% | 525,000 (+15.11%) | Filing History |
| 2025-11-14 4:11 pm Purchase | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Point72 Asset Management, L.P. | 1,053,983 8.000% | 465,351 (+79.06%) | Filing History |
| 2025-11-14 4:10 pm Sale | 2025-09-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Point72 Asset Management, L.P. | 2,801,636 2.600% | -1,916,073 (-40.61%) | Filing History |
| 2025-11-14 4:09 pm Purchase | 2025-09-30 | 13G | AngioDynamics, Inc. ANGO | Point72 Asset Management, L.P. | 2,559,389 6.200% | 439,187 (+20.71%) | Filing History |
| 2025-11-14 4:09 pm Purchase | 2025-09-30 | 13G | Zepp Health Corporation ZEPP | Point72 Asset Management, L.P. | 8,777,008 7.600% | 2,304,784 (+35.61%) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | Teladoc Health, Inc. TDOC | Point72 Asset Management, L.P. | 5,795,178 3.300% | -3,031,172 (-34.34%) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 4,068,575 2.500% | -4,016,048 (-49.68%) | Filing History |
| 2025-11-14 4:07 pm Sale | 2025-09-30 | 13G | Arcus Biosciences, Inc. RCUS | Point72 Asset Management, L.P. | 4,332,479 4.100% | -1,498,620 (-25.70%) | Filing History |
| 2025-11-14 4:07 pm Sale | 2025-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 3,209,645 4.500% | -2,685,424 (-45.55%) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | Entera Bio Ltd. ENTX | Point72 Asset Management, L.P. | 1,183,116 2.600% | -1,518,444 (-56.21%) | Filing History |
| 2025-11-14 4:05 pm Sale | 2025-09-30 | 13G | Tower Semiconductor Ltd. TSEM | Point72 Asset Management, L.P. | 2,854,352 2.600% | -3,485,625 (-54.98%) | Filing History |
| 2025-11-14 4:05 pm Sale | 2025-09-30 | 13G | PagSeguro Digital Ltd. PAGS | Point72 Asset Management, L.P. | 10,147,152 5.700% | -2,299,959 (-18.48%) | Filing History |